Bright Minds Biosciences Inc.

Cormorant Asset Management, Lp sold 109,331 shares of DRUG on 28 April. They now own 950,000 DRUG shares.

Cormorant Asset Management, Lp bought 184,331 shares of DRUG on 4 November. They now own 1,059,331 DRUG shares.

Cormorant Asset Management, Lp bought 3,107 shares of DRUG on 16 October. They now own 875,000 DRUG shares.

Cormorant Asset Management, Lp bought 39,743 shares of DRUG on 16 October. They now own 864,743 DRUG shares.

Cormorant Asset Management, Lp bought 7,150 shares of DRUG on 16 October. They now own 871,893 DRUG shares.

Cormorant Asset Management, Lp bought 2,600 shares of DRUG on 15 October. They now own 798,522 DRUG shares.

Cormorant Asset Management, Lp bought 63,173 shares of DRUG on 15 October. They now own 753,679 DRUG shares.

Cormorant Asset Management, Lp bought 4,609 shares of DRUG on 15 October. They now own 825,000 DRUG shares.

Cormorant Asset Management, Lp bought 2,700 shares of DRUG on 15 October. They now own 801,222 DRUG shares.

Cormorant Asset Management, Lp bought 33,343 shares of DRUG on 15 October. They now own 787,022 DRUG shares.

Cormorant Asset Management, Lp bought 0 shares of DRUG on 15 October. They now own 452,409 DRUG shares.

Cormorant Asset Management, Lp bought 8,900 shares of DRUG on 15 October. They now own 795,922 DRUG shares.

Cormorant Asset Management, Lp bought 238,097 shares of DRUG on 15 October. They now own 690,506 DRUG shares.

Cormorant Asset Management, Lp bought 19,169 shares of DRUG on 15 October. They now own 820,391 DRUG shares.